Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 Per Share
-
Shares outstanding
-
14,033,333
-
Total 13F shares
-
13,510,739
-
Share change
-
-37,230
-
Total reported value
-
$611,370,033
-
Put/Call ratio
-
3.8%
-
Price per share
-
$45.26
-
Number of holders
-
154
-
Value change
-
+$251,984
-
Number of buys
-
58
-
Number of sells
-
78
Institutional Holders of Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) as of Q4 2020
As of 31 Dec 2020,
Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) was held by
154 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,510,739 shares.
The largest 10 holders included
BlackRock Inc., KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, Avidity Partners Management LP, Boston Trust Walden Corp, and NORTHERN TRUST CORP.
This page lists
154
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.